Hesperidin and tiger nut reduced carcinogenicity of DMBA in female rats - 21/10/16
, Abdel Karim M. Abdel Latif b, Ayman M. Abdel-Aziz b, Alshimaa M. Amin aBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Nutritional studies recommend the regular consumption of fruits and vegetables to favor a healthy quality of life. This study was carried out to evaluate the efficacy of hesperidin and tiger nut against the carcinogenic activity of DMBA in female rats. 72 adult Sprague Dawley female rats were divided equally into six groups: control group (I); Hesperidin treated group (II); Tiger Nut treated group (III); DMBA treated group (IV); HES-DMBA treated group (V); and TN-DMBA treated group (VI). There was a significant increase in serum levels of carcinoembryonic antigen, total sialic acid, progesterone, estradiol, ALT, AST, LDH, urea and creatinine, and significant decrease in reduced glutathione level, superoxide dismutase, catalase and glutathione peroxidase activities of DMBA treated group compared to control. In conclusion, our results suggested that supplementation of diets with hesperidin provided antioxidant and chemoprotective activities more significant than tiger nut against the toxicity of DMBA in breast, liver and kidney tissues.
Le texte complet de cet article est disponible en PDF.Abbreviations : HES, TN, DMBA, CEA, TSA, CO, MDA, ALT, AST, LDH, GSH, SOD, CAT, GSH-Px
Keywords : DMBA, Hesperidin, Tiger nut, CEA, Progesterone, Estradiol
Plan
Vol 83
P. 718-724 - octobre 2016 Retour au numéro
Article précédent
- Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer
- Wei Peng, Airen Jiang
- Rosemary extract reduces Akt/mTOR/p70S6K activation and inhibits proliferation and survival of A549 human lung cancer cells
- Jessy Moore, Mark Megaly, Adam J. MacNeil, Panagiota Klentrou, Evangelia Tsiani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?